HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masakazu Ichinose Selected Research

ErbB Receptors (EGF Receptor)

11/2019Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas.
3/2019Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations.
6/2017Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer.
5/2015Anterior gradient 2 is correlated with EGFR mutation in lung adenocarcinoma tissues.
1/2014Effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masakazu Ichinose Research Topics

Disease

82Chronic Obstructive Pulmonary Disease (COPD)
03/2024 - 01/2004
48Asthma (Bronchial Asthma)
08/2024 - 03/2003
33Inflammation (Inflammations)
08/2024 - 01/2002
12Neoplasms (Cancer)
01/2020 - 12/2006
9Dyspnea (Shortness of Breath)
01/2020 - 02/2010
7Pneumonia (Pneumonitis)
01/2020 - 08/2011
7Lung Neoplasms (Lung Cancer)
11/2019 - 10/2004
6Lung Diseases (Lung Disease)
05/2018 - 01/2004
6Virus Diseases (Viral Diseases)
01/2018 - 06/2009
5Emphysema
03/2024 - 10/2017
5Infections
05/2020 - 01/2016
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2019 - 01/2014
5Fibrosis (Cirrhosis)
09/2013 - 01/2005
4Hypersensitivity (Allergy)
10/2020 - 01/2014
4Allergic Rhinitis
10/2020 - 03/2009
4Adenocarcinoma of Lung
11/2019 - 05/2015
4Pulmonary Alveolar Proteinosis
01/2018 - 04/2006
3Eosinophilia
08/2024 - 01/2002
3Sarcoidosis (Schaumann Disease)
01/2022 - 04/2004
3Neoplasm Metastasis (Metastasis)
11/2019 - 12/2005
3Adenocarcinoma
11/2019 - 01/2014
3Nasopharyngitis
10/2018 - 07/2013
3Disease Progression
10/2018 - 04/2004
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2017 - 04/2006
2Airway Obstruction (Choking)
11/2021 - 01/2005
2Rhinosinusitis
10/2020 - 04/2017
2Otitis
10/2020 - 04/2017
2Glaucoma
01/2020 - 10/2005
2Hepatitis
01/2020 - 10/2005
2Obstructive Lung Diseases (Obstructive Lung Disease)
01/2019 - 01/2011
2Liver Diseases (Liver Disease)
10/2018 - 08/2005
2Granuloma
05/2018 - 02/2016

Drug/Important Bio-Agent (IBA)

29Adrenal Cortex Hormones (Corticosteroids)IBA
10/2023 - 04/2004
16Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2024 - 02/2008
16Bronchodilator Agents (Bronchodilators)IBA
01/2021 - 01/2005
13CytokinesIBA
07/2022 - 09/2004
11Proteins (Proteins, Gene)FDA Link
05/2020 - 01/2004
10Tiotropium Bromide (Spiriva)FDA Link
01/2019 - 02/2010
8Immunoglobulin E (IgE)IBA
08/2024 - 01/2011
8Muscarinic AntagonistsIBA
10/2020 - 01/2017
8GoldIBA
01/2020 - 11/2004
7SteroidsIBA
10/2020 - 10/2005
7Oxygen (Dioxygen)IBA
10/2020 - 01/2014
6Biomarkers (Surrogate Marker)IBA
08/2024 - 04/2006
6Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
10/2020 - 03/2011
6tiotropium-olodaterolIBA
01/2019 - 01/2016
5Messenger RNA (mRNA)IBA
01/2022 - 01/2007
5SuspensionsIBA
08/2021 - 08/2014
5Theophylline (Theon)FDA LinkGeneric
10/2020 - 03/2011
5Interleukin-8 (Interleukin 8)IBA
05/2020 - 03/2006
5Formoterol Fumarate (Oxis)FDA Link
05/2020 - 01/2008
5ErbB Receptors (EGF Receptor)IBA
11/2019 - 01/2014
5olodaterolIBA
01/2018 - 01/2015
4AntibodiesIBA
10/2023 - 03/2006
4Phosphotransferases (Kinase)IBA
07/2022 - 07/2004
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
07/2022 - 01/2002
4EnzymesIBA
01/2022 - 01/2007
4Epinephrine (Adrenaline)FDA LinkGeneric
10/2020 - 01/2014
4Aminophylline (Carine)FDA LinkGeneric
10/2020 - 01/2014
4ChemokinesIBA
11/2019 - 09/2004
4indacaterolIBA
01/2017 - 11/2010
4Transcription Factors (Transcription Factor)IBA
01/2016 - 08/2014
4Reactive Nitrogen SpeciesIBA
04/2012 - 01/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009 - 09/2004
3RNA (Ribonucleic Acid)IBA
03/2024 - 10/2005
3Immunoglobulins (Immunoglobulin)IBA
10/2022 - 10/2005
3Factor XI (Plasma Thromboplastin Antecedent)IBA
01/2021 - 10/2017
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 01/2016
3Budesonide (Pulmicort)FDA LinkGeneric
05/2020 - 04/2013
3Chemokine ReceptorsIBA
11/2019 - 09/2004
3budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA
01/2019 - 10/2018
3AntioxidantsIBA
01/2018 - 01/2007
3Salmeterol Xinafoate (Serevent)FDA Link
01/2017 - 01/2005
3NitrogenIBA
01/2016 - 09/2007
3CollagenIBA
01/2015 - 01/2005
325-hydroxycholesterolIBA
05/2013 - 04/2012
3CholesterolIBA
05/2013 - 04/2012
3tulobuterolIBA
06/2012 - 01/2005
33-nitrotyrosineIBA
09/2009 - 01/2004
3Reactive Oxygen Species (Oxygen Radicals)IBA
09/2009 - 01/2005
2Sialic Acid Binding Ig-like Lectin 1IBA
03/2024 - 01/2020
2Indicators and Reagents (Reagents)IBA
11/2021 - 11/2019
2Pancreatic Elastase (Elastase)IBA
08/2021 - 10/2017
2Interleukin-6 (Interleukin 6)IBA
05/2020 - 07/2012
2Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
05/2020 - 01/2017
2AlbuminsIBA
01/2020 - 01/2020
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2019 - 01/2018
2ceritinibIBA
10/2018 - 01/2017
2Anaplastic Lymphoma KinaseIBA
10/2018 - 01/2014
2CrizotinibIBA
10/2018 - 08/2013
2InterleukinsIBA
10/2018 - 03/2006
2Cholinergic Agents (Cholinergics)IBA
10/2018 - 01/2018
2Acetylcholine (Acetylcholine Chloride)FDA Link
10/2018 - 01/2018
2Pepsin A (Pepsin)IBA
01/2018 - 03/2015

Therapy/Procedure

46Therapeutics
10/2023 - 04/2004
10Drug Therapy (Chemotherapy)
10/2020 - 09/2005
3Nebulizers and Vaporizers (Inhaler)
01/2017 - 01/2015
2Bronchial Thermoplasty
10/2020 - 04/2017
2Immunotherapy
01/2020 - 01/2019
2Metered Dose Inhalers (Metered Dose Inhaler)
01/2019 - 01/2019